Ramiah Investment Group

Position in BMY — Bristol Myers Squibb Co

CIK 1566307 BROOKFIELD, WI

Position in BMY

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$222,816

-$20,269 QoQ

Shares Held

3,867

-3.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.47%

of 13F equity value

Holder Rank

#2,087

of 2,514 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Ramiah Investment Group holds $2,594,267 across 6 Drug Manufacturers - General names. BMY ranks #6 (8.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	4,246	$545,611
2	AMGN	Amgen Inc	1,454	$526,522
3	ABBV	AbbVie Inc.	1,865	$469,308
4	BIIB	Biogen Inc.	2,085	$450,485
5	GILD	Gilead Sciences, Inc.	3,004	$379,525
6	BMY	Bristol Myers Squibb Co This page	3,867	$222,816

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$222,816	3,867	-3.5%	Shares	Sole	2026-07-16
2026-03-31	$243,085	4,008	-4.8%	Shares	Sole	2026-05-29
2025-12-31	$227,087	4,210	—	Shares	Sole	2026-05-29
No filing history on record for this holder in this stock.